Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Norhammar

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
JAMA Network Open|April 30, 2026
Pregestational Cardiometabolic Biomarkers and Future Hypertensive Disorders of PregnancyAngelika Qvick, Anna Sandström, Anna Norhammar, et al.
BMJ Open|January 17, 2025
Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profileHannah Coudé Adam, Omid Hajimirsadeghi, Lovisa Krantz, et al.
ESC Heart Failure|February 5, 2024
Heart failure outcomes by left ventricular ejection fraction in a contemporary region-wide patient cohortJohan Sundström, Johan Ärnlöv, Stelios Karayiannides, et al.
Upsala Journal of Medical Sciences|June 20, 2022
Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based studyMaria K Svensson, Francesc Sorio Vilela, Margrét Leósdóttir, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction studyLisa Arnetz, Camilla Hage, Kerstin Brismar, et al.
Cardiovascular Diabetology|August 11, 2023
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trialElena Fortin, Magnus Lundin, Linda Mellbin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
Diabetes & Vascular Disease Research|September 4, 2019
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART studyViveca Ritsinger, Jens Jensen, Daniel Ohm, et al.
Journal of Clinical Periodontology|April 29, 2017
Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patientsNilminie Rathnayake, Kåre Buhlin, Barbro Kjellström, et al.
Cardiovascular Diabetology|July 8, 2022
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohortSara Meziani, Giulia Ferrannini, Mette Bjerre, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
JAMA Network Open|April 30, 2026
Pregestational Cardiometabolic Biomarkers and Future Hypertensive Disorders of PregnancyAngelika Qvick, Anna Sandström, Anna Norhammar, et al.
BMJ Open|January 17, 2025
Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profileHannah Coudé Adam, Omid Hajimirsadeghi, Lovisa Krantz, et al.
ESC Heart Failure|February 5, 2024
Heart failure outcomes by left ventricular ejection fraction in a contemporary region-wide patient cohortJohan Sundström, Johan Ärnlöv, Stelios Karayiannides, et al.
Upsala Journal of Medical Sciences|June 20, 2022
Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based studyMaria K Svensson, Francesc Sorio Vilela, Margrét Leósdóttir, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction studyLisa Arnetz, Camilla Hage, Kerstin Brismar, et al.
Cardiovascular Diabetology|August 11, 2023
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trialElena Fortin, Magnus Lundin, Linda Mellbin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
Diabetes & Vascular Disease Research|September 4, 2019
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART studyViveca Ritsinger, Jens Jensen, Daniel Ohm, et al.
Journal of Clinical Periodontology|April 29, 2017
Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patientsNilminie Rathnayake, Kåre Buhlin, Barbro Kjellström, et al.
Cardiovascular Diabetology|July 8, 2022
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohortSara Meziani, Giulia Ferrannini, Mette Bjerre, et al.
Pageof 11